|4Jun 6, 5:11 PM ET

Housley Andrece 4

4 · Insys Therapeutics, Inc. · Filed Jun 6, 2019

Insider Transaction Report

Form 4
Period: 2019-04-17
Housley Andrece
Chief Financial Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-04-17+31,00831,008 total
    Exercise: $4.30Exp: 2029-04-16Common Stock (31,008 underlying)
  • Award

    Common Stock

    2019-04-17+3,99220,994 total
Footnotes (1)
  • [F1]The option vests in 48 equal monthly installments and will be fully vested and exercisable on April 17, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION